Drug General Information
Drug ID	D07GWS
Former ID	DNC000173
Drug Name	Alanosine
Drug Type	Small molecular drug
Indication	Discovery agent		Phase 2	[521559]
Structure		Download 2D MOL 3D MOL
Formula	C3H7N3O4
Canonical SMILES	C(C(C(=O)O)N)N(N=O)O
InChI	1S/C3H7N3O4/c4-2(3(7)8)1-6(10)5-9/h2,10H,1,4H2,(H,7,8)
InChIKey	MLFKVJCWGUZWNV-UHFFFAOYSA-N
CAS Number	CAS 475-38-7
PubChem Compound ID	98513
PubChem Substance ID	482981, 559469, 7506783, 8137413, 8140284, 10229805, 11405478, 11408691, 12015173, 44428777, 50025452, 50325474, 57336713, 103124646, 103193246, 104423122, 117543580, 125566931, 125809880, 128611925, 134339683, 135056893, 137088039, 139036460, 162253745, 162546986, 164835164, 179225486, 231597823
Target and Pathway
Target(s)	Adenylosuccinate synthetase	Target Info	Inhibitor	[536240]
References
Ref 521559	ClinicalTrials.gov (NCT00062283) Alanosine in Treating Patients With Cancer. U.S. National Institutes of Health.
Ref 536240	Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy. Clin Cancer Res. 2006 Jun 15;12(12):3754-61.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.